Correlating Drug-Target Kinetics and In vivo Pharmacodynamics: Long Residence Time Inhibitors of the FabI Enoyl-ACP Reductase.
about
A quantitative mechanistic PK/PD model directly connects Btk target engagement and in vivo efficacyDrug-target interaction kinetics: underutilized in drug optimization?Drug-Target Kinetics in Drug Discovery.Rationalizing the Binding Kinetics for the Inhibition of the Burkholderia pseudomallei FabI1 Enoyl-ACP Reductase.
P2860
Correlating Drug-Target Kinetics and In vivo Pharmacodynamics: Long Residence Time Inhibitors of the FabI Enoyl-ACP Reductase.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Correlating Drug-Target Kineti ...... the FabI Enoyl-ACP Reductase.
@en
type
label
Correlating Drug-Target Kineti ...... the FabI Enoyl-ACP Reductase.
@en
prefLabel
Correlating Drug-Target Kineti ...... the FabI Enoyl-ACP Reductase.
@en
P2093
P2860
P356
P1433
P1476
Correlating Drug-Target Kineti ...... the FabI Enoyl-ACP Reductase.
@en
P2093
Andrew Chang
Christoph A Sotriffer
Fereidoon Daryaee
Johannes Schiebel
Kanishk Kapilashrami
Stephen G Walker
Stewart L Fisher
Zhuo Zhang
P2860
P304
P356
10.1039/C6SC01000H
P577
2016-05-25T00:00:00Z